Restless Legs Syndrome Market Key Players – Bioprojet SCR, Galenica Ltd, Hisamitsu Pharmaceutical Co Inc and Omeros Corp Inc Analysis & Forecast 2018 to 2022

Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a disorder of the part of the nervous system that affects the legs and causes an urge to move them.

Symptoms include itching, pain, a creepy-crawly feeling and cramping in the calf’s or legs. Predisposing factor includes age. Treatment includes muscle relaxants, sleep medications and narcotic medications.

Click here for sample report @…

Top Companies mentioned

Bioprojet SCR

Galenica Ltd

Hisamitsu Pharmaceutical Co Inc

Merz Pharma GmbH & Co KgaA

Mundipharma International Ltd

Omeros Corp

Serina Therapeutics Inc

Restless Legs Syndrome Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Restless Legs Syndrome  – Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Restless Legs Syndrome , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Restless Legs Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Restless Legs Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Preclinical stages are 1, 1, 3, 2 and 3 respectively.

Restless Legs Syndrome pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Restless Legs Syndrome – Competitive Analysis

Key players are making innovative developments in Restless Legs Syndrome industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector


The pipeline guide provides a snapshot of the global therapeutic landscape of Restless Legs Syndrome.

The pipeline guide reviews pipeline therapeutics for Restless Legs Syndrome by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Restless Legs Syndrome therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Restless Legs Syndrome therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Restless Legs Syndrome.


For Detailed Reading Please visit @…

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Office No. 528, Amanora Chambers
Pune – 411028
Maharashtra, India

This release was published on openPR.

Leave a Reply

Your email address will not be published. Required fields are marked *

Designed by
Powered by